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Letters to the EditorReply to: ‘‘Mid-regional pro-adrenomedullin (MR-proADM): An
even better prognostic biomarker than C reactive protein to
predict short-term survival in patients with decompensated
cirrhosis at risk of infection?’’To the Editor:
We thank Reuken et al. for their interest in our study. The prognos-
tic evaluation of cirrhotic patients has improved in the last decade
or so, with the consideration of extrahepatic complications com-
mon in cirrhosis, and with the dynamic assessment of prognostic
scores. The ﬁrst extrahepatic complication taken into account was
hepatorenal syndrome, justifying the incorporation of serum cre-
atinine in theMELD score. More recently, Arvaniti et al. proposed a
prognostic classiﬁcation in which bacterial infection deﬁned the
more severe stage of cirrhosis [1]. However, bacteriological tests
that are mandatory for the diagnosis of infection may lack sensi-
tivity in cirrhosis. Moreover, systemic inﬂammation associated
with bacterial infectionmay persist, even after appropriate antibi-
otic treatment, thus having an impact on prognosis. Recently, the
analysis of a large European cohort has conﬁrmed that the occur-
rence of an acute-on-chronic liver failure is associated with sys-
temic inﬂammation even in non-infected patients [2]. This is
why our study (1) focused on a marker of systemic inﬂammation
(rather than a marker of infection) and (2) considered as relevant
only the case of persistent elevation of CRP for 15 days [3].
New prognostic markers are currently under evaluation in cir-
rhosis. Most of them are inﬂuenced by systemic inﬂammation. For
example, our groupdemonstrated that elevated serumfree cortisol
is associatedwithhighCRP levels and increasedmortality inhemo-
dynamically stable cirrhotic patients [4]. Copeptin, a surrogate of
AVP secretion, also increases in the event of systemic inﬂammation
[5] and recently appeared as a promising prognostic marker in cir-
rhotic patients [6]. For all these new markers, it seems important
todeterminetheircorrelationwithCRP levels. Inaddition,essential1158 Journal of Hepatology 201information for the clinician is their speciﬁc weight for prognosis,
independentofMELDandCRP. Indeed,althoughthesenewmarkers
appear attractive through their pathophysiological background,
they are not routinely available, conversely to CRP.
The results presented by Reuken et al. are very interesting but
deserve some comments. In their population including a majority
of infected patients (52%), the mid regional fragment of pro-adre-
nomedullin (MR-proADM) appeared to be a reliable marker of
spontaneous bacterial peritonitis (SBP). The authors emphasize
the relationship between MR-proADM and SBP rather than sys-
temic inﬂammation. We acknowledge that MR-proADM was a
better diagnostic marker of SBP than CRP. However, given the high
prevalence of infected patients and the more marked increase of
MR-proADM in the event of bacterial infection in the study of
Reuken et al. the prognostic value of MR-proADM remains to be
demonstrated in non-infected cirrhotic patients. The authors
should have provided speciﬁc data on this subgroup of patients.
Another comment concerns the statistical method used by the
authors. Their multivariate model seems questionable since
MR-proADM, bacterial infection, SIRS, and MELD were imple-
mented as independent variables, whereas univariate analyses
showed that MR-proADM was signiﬁcantly correlated with INR
and creatinine, and was a ‘‘poor’’ but signiﬁcant predictor of bac-
terial infection. Hence, the question of the true independent prog-
nostic value of MR-proADM remains unresolved. In our study, CRP
andMELDwere not collinear, thus allowing us to state that persis-
tently high CRP levels provided greater accuracy than the simple
measurement of MELD for evaluating prognosis in cirrhotic
patients.2 vol. 57 j 1152–1159
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